grant
IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES IDIQ CONTRACT. POP 9/27/21-9/26/26. NTE $3.5 MILLION. FIRST TASK ORDER 01 OBLIGATED IN THE AMOUNT O
Organization SRI INTERNATIONALLocation MENLO PARK, UNITED STATESPosted 27 Sept 2021Deadline 26 Sept 2026
NIHUS FederalResearch GrantFY2021ADME StudyAbsorption, Distribution, Metabolism, and Excretion StudyContracting OpportunitiesContractsDataDrugsFood and Drug AdministrationIn VitroIntermediary MetabolismInvestigational DrugsInvestigational New DrugsInvestigatorsMedicationMetabolic ProcessesMetabolismNIDANational Institute of Drug AbuseNational Institute on Drug AbusePermeabilityPharmaceutic PreparationsPharmaceutical PreparationsProgram DevelopmentResearch PersonnelResearchersUSFDAUnited States Food and Drug Administrationdrug/agentin vivonew drug treatmentsnew drugsnew therapeuticsnew therapynext generation therapeuticsnovel drug treatmentsnovel drugsnovel therapeuticsnovel therapy
Full Description
The objective of this contract is to carry out in vitro metabolism and permeability and in vivo ADME studies to support the medications development program of the National Institute on Drug Abuse (NIDA). NIDA and NIDA sponsored investigators will use the data obtained for submissions to the Food and Drug Administration (FDA) in support of Investigational New Drugs (INDs) and New Drug Applications (NDAs).
Grant Number: 75N95021D00025-0-9999-1
NIH Institute/Center: NIH
Principal Investigator: MARY BASTIDA
Sign up free to get the apply link, save to pipeline, and set email alerts.
Sign up free →Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click